United Health Share Price – Live Quote, Targets and Analysis

UnitedHealth Group (UNH) commands attention as one of the largest healthcare conglomerates trading on the New York Stock Exchange, yet its stock trajectory over the past twelve months has tested investor resolve. Shares have navigated extreme volatility, swinging between highs above $600 and lows near $230, creating uncertainty for portfolio managers tracking the managed care sector.

The current pricing environment reflects complex pressures facing the healthcare giant, including strategic shifts in Medicare Advantage membership and evolving analyst sentiment. Real-time data from market sources indicates the stock trades between $277 and $315 depending on session timing, with market capitalization compressed to approximately $251–280 billion.

For investors evaluating entry points or assessing existing positions, understanding the precise market data and contextual factors driving these movements proves essential. This analysis examines the live quotation metrics, financial fundamentals, and expert projections defining UnitedHealth’s market position.

What is the Current UnitedHealth Stock Price and Recent Performance?

• The stock has declined nearly 50% from its 52-week high of $622.83, recorded in previous trading sessions.
• Recent trading volume of 8.18 million shares sits slightly below the daily average of 8.6 million.
• Price action shows recovery attempts from the 52-week low of $234.60, though volatility persists.
• Intraday spreads have exceeded $10 in recent sessions, indicating elevated short-term uncertainty.
• Market capitalization has compressed significantly from peak valuations, now ranging between $251–280 billion.
• The current price sits substantially below Morningstar’s fair value estimate of $439.00.
• Analyst consensus suggests 22.7% upside potential based on current price targets.

What Are UnitedHealth’s Key Financial Metrics Like Dividend and PE Ratio?

UnitedHealth maintains several financial metrics that distinguish it within the healthcare sector, particularly regarding income generation and valuation multiples. The stock currently offers a dividend yield of approximately 2.8%, providing income stability amid price volatility.

Dividend Yield and Income Stability

The 2.8% dividend yield represents a significant component of total return for long-term shareholders, particularly during periods of price depreciation. This yield compares favorably within the managed care sector, offering investors compensation while awaiting price recovery. The company has historically maintained consistent payout ratios, though future increases depend on earnings stability and cash flow generation.

Price-to-Earnings and Valuation Multiples

Valuation metrics reveal a company trading at potentially discounted levels relative to sector peers. Data from Investing.com indicates UNH trades at a P/E ratio of 11.1x, below the sector average of 12.1x. The Price/Book ratio stands at 2.5x, while the Price/LTM Sales ratio of 0.6x represents a significant discount to the sector average of 3.3x.

Market Capitalization and Scale

Despite recent compression, UnitedHealth maintains a market capitalization between $251–280 billion, positioning it among the largest healthcare entities globally. This scale provides competitive advantages in negotiating provider contracts and managing pharmacy benefit costs, though it also attracts regulatory scrutiny regarding market concentration.

What Is the 52-Week Range and Historical Context for UNH Stock?

The past twelve months have delivered extraordinary volatility for UnitedHealth shareholders, with the stock experiencing one of its most dramatic drawdowns in recent history. Understanding this range provides essential context for evaluating current risk-reward profiles.

Extreme Volatility Over the Past Year

Trading data compiled by Robinhood indicates the stock reached a 52-week high of $622.83 before collapsing to a low of $234.60. Analysis from Finviz confirms the stock lost nearly half its value over the past year before showing tentative signs of stabilization. This 62% peak-to-trough decline erased billions in market value and tested support levels not seen in previous years.

Stock Split Considerations

Whether UnitedHealth has executed recent stock splits remains unclear based on available documentation. Investors seeking historical split-adjusted prices should verify through official SEC filings or company investor relations materials to ensure accurate long-term performance calculations.

What Are Analyst Price Targets and Forecasts for UnitedHealth Stock?

Professional analysts display mixed but recently improving sentiment toward UnitedHealth, with significant dispersion in price targets reflecting fundamental uncertainty about the company’s trajectory. The consensus suggests substantial upside potential, though individual estimates vary dramatically.

Recent Rating Changes and Upgrades

According to analyst tracking data, Raymond James provided the most recent significant upgrade on April 1, 2026, elevating UNH from Market Perform to Outperform with a $330 price target. This upgrade contrasts with earlier downgrades from Deutsche Bank in October 2025 and Robert W. Baird in July 2025, suggesting shifting institutional confidence in the company’s operational turnaround.

Consensus Price Targets and Upside Potential

Data indicates the average analyst price target stands at $446, with individual estimates ranging from $270 to $600. This wide dispersion—spanning $330—reflects genuine uncertainty about Medicare Advantage profitability, regulatory risks, and overall healthcare utilization trends. The consensus target implies 22.7% upside potential from current trading levels, though investors should note that targets exceeding $500 appear increasingly disconnected from recent fundamentals.

Why Has UnitedHealth Stock Price Changed Recently?

Several concrete corporate actions and market reactions have driven recent price movements, creating a timeline of events that explains the stock’s dramatic repricing. These developments center on strategic business decisions and shifting institutional sentiment.

1. April 1, 2026: Raymond James upgrades UNH from Market Perform to Outperform with $330 target, sparking initial recovery momentum.
2. Q1 2026: UnitedHealth announces plans to drop 1 million Medicare Advantage members, signaling strategic retrenchment from unprofitable lines.
3. Q1 2026: Board authorizes $222.29 million share buyback program alongside bylaw amendments regarding Delaware registration.
4. October 2025: Deutsche Bank issues downgrade, contributing to downward pressure on shares.
5. July 2025: Robert W. Baird downgrades stock, citing operational concerns and margin pressures.
6. Previous 12 Months: Stock declines from $622.83 high to $234.60 low amid broader healthcare sector concerns and company-specific utilization challenges. Comprehensive quote data available via financial platforms.

What Is Certain About UnitedHealth’s Stock Price vs. What Remains Uncertain?

Distinguishing between verified data points and speculative projections remains crucial for investors evaluating UNH. The following breakdown separates established facts from unresolved questions influencing valuation.

What Broader Factors Contextualize UnitedHealth’s Share Price?

UnitedHealth operates at the intersection of healthcare provision, insurance underwriting, and pharmacy benefit management, exposing its stock to multifaceted macroeconomic pressures. The company’s What Is a Dependent Variable – Definition, Examples, Key Differences in stock performance include Medicare reimbursement rates, commercial insurance utilization trends, and pharmaceutical cost inflation—factors that interact complexly to determine profitability margins.

The recent decision to reduce Medicare Advantage membership by 1 million lives reflects broader industry challenges regarding medical loss ratios and regulatory pressure on supplemental benefits. Historical trading data from exchange sources indicates this strategic contraction, while potentially damaging to top-line growth, may improve underlying profitability metrics that analysts monitor when setting price targets.

Sector-wide valuation compression has affected managed care organizations broadly, though UnitedHealth’s decline has outpaced many peers. The stock’s current trading multiples suggest investors price in sustained operational headwinds, requiring tangible evidence of margin stabilization before supporting higher valuations.

What Do Primary Sources Indicate About UNH Valuation?

Financial data providers offer varying perspectives on UnitedHealth’s current standing, with methodological differences explaining some price discrepancies. Official filings available through SEC EDGAR system provide the authoritative source for corporate actions and financial statements.

UNH trades at approximately $277.26 with a market capitalization of $251-280 billion… The stock shows a dividend yield of 2.8-2.79% and trades at a P/E ratio ranging from 11.1x to 20.95.

— Morningstar and Robinhood composite data

The average analyst price target stands at $446, with estimates ranging from $270 to $600… Analyst upside potential of 22.7% based on current targets.

— Investing.com consensus analysis

Raymond James upgraded UNH from Market Perform to Outperform on April 1, 2026, with a $330 price target.

— Finviz analyst tracking

How Should Investors Interpret UnitedHealth’s Current Stock Price?

UnitedHealth Group presents a contrarian opportunity marked by substantial analyst upside targets and compressed valuation multiples, yet burdened by operational uncertainties regarding Medicare Advantage profitability. The stock’s 50% decline from peak levels has created a potential value proposition for risk-tolerant investors, though the wide dispersion in analyst targets—from $270 to $600—demands careful due diligence. With a 2.8% dividend yield providing income support and recent upgrades suggesting improving sentiment, UNH requires monitoring of quarterly membership trends and margin stabilization before clear directional conviction emerges. Investors staying informed through Is Fortnite Down – Live Status Check Right Now and official SEC filings can better track the volatility defining this healthcare giant’s current market phase.

Frequently Asked Questions About UnitedHealth Stock